MétaCan
Menu
Back to cohort
Record W4415713040 · doi:10.1158/0008-5472.can-25-0881

Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery

2025· article· en· W4415713040 on OpenAlexafffund
Aleksandr Ianevski, Kristen Nader, Julia Nguyen, Helena Sorger, Sanna Timonen, Edith Julia, Daniel Pölöske, Katrin Spirk, Christina Wagner, Dennis Jungherz, Minoru Nakano, Sisira Kadambat Nair, Philipp Ianevski, Matti Kankainen, Diogo Dias, Anna Cichońska, Tea Pemovska, Christine Pirker, Walter Berger, Till Braun, Richard Moriggl, Emmanuel Bachy, Satu Mustjoki, Marco Herling, Heidi A. Neubauer, Benjamin Haibe‐Kains, Tero Aittokallio

Bibliographic record

VenueCancer Research · 2025
Typearticle
Languageen
FieldImmunology and Microbiology
TopicT-cell and Retrovirus Studies
Canadian institutionsArtificial Intelligence in Medicine (Canada)Vector InstituteStructural Genomics ConsortiumPrincess Margaret Cancer CentreUniversity of TorontoUniversity Health Network
FundersInstitute of GeneticsHelsinki Institute of Life Science, Helsingin YliopistoBreak Through CancerBiocenter FinlandUniversität WienEuropean CommissionHelsingin YliopistoPfizerIncyteAmerican Association for Cancer ResearchAmgenAustrian Science FundSyöpäsäätiöMedizinische Universität WienBeiGeneChina Scholarship CouncilQuébec Consortium for Drug DiscoveryNorges ForskningsrådAcademy of FinlandKreftforeningenGilead SciencesBristol-Myers SquibbSigrid Juséliuksen SäätiöSigne ja Ane Gyllenbergin Säätiö
KeywordsLymphomaLeukemiaProfiling (computer programming)DrugBiomarker discoveryDrug discovery

Abstract

fetched live from OpenAlex

T-cell leukemias and lymphomas (TCL) form a heterogeneous group of rare and often aggressive malignancies. Because of the rarity and heterogeneity of TCL subtypes, clinical trials are challenging to conduct, making pharmacogenomic studies in cell line panels critical for the discovery of targeted therapeutics. The scarcity of data repositories with integrated multiomics and drug screening data hinders the preclinical evaluation of drug vulnerabilities and the identification of molecular markers predictive of responses to monotherapies and combinations. To address this gap, we conducted comprehensive pharmacogenomic profiling on a panel of 38 TCL cell lines, representing major clinical TCL subtypes to capture the molecular and phenotypic diversity. The TCL-38 multiomics data resource includes harmonized genetic, molecular, and epigenetic profiles, with comprehensive annotations and standardized drug response assessment of each cell line. This resource, together with machine learning predictions, was leveraged to identify TCL subtype-specific therapeutic vulnerabilities, including single-agent sensitivities and synergistic drug combinations, which were linked to genetic or epigenetic features as potential predictive biomarkers. This integrated and openly available resource (https://aittokallio.group/tcl38) could help advance the currently limited treatment options for patients with TCL. SIGNIFICANCE: Integrated and harmonized multiomics analyses and drug screening across a heterogeneous panel of T-cell leukemias and lymphomas provide a resource to uncover drug targets and predictive biomarkers to improve patient outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.069
Threshold uncertainty score0.306

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.329
Teacher spread0.296 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueCancer ResearchSame topicT-cell and Retrovirus StudiesFrench-language works237,207